FAKTOR-OPTIONSSCHEIN - INCYTE CO. Share Price

DE000SD42FL9

Market Closed - Boerse Frankfurt Warrants 20:41:14 24/05/2024 BST
1.15 ^EUR	-2.54%

Current month	+28.57%
1 month	+31.46%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	05-23	MT
Incyte Acquires 2 Office Buildings in Delaware	05-21	MT
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings	05-21	BU
Incyte to Present at Upcoming Investor Conference	05-21	BU

More news

Quotes 5-day view

Date	Price	Change
24/05/24	1.17	-0.85%
23/05/24	1.18	-2.48%
22/05/24	1.21	+4.31%
21/05/24	1.16	+1.75%
20/05/24	1.14	-0.87%

Real-time Boerse Frankfurt Warrants

Last update May 24, 2024 at 08:41 pm

More quotes

Static data

Product type	Exotische Produkte
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Société Générale
WKN	SD42FL
ISIN	DE000SD42FL9
Date issued	29/03/2021
Strike	79.94 $
Maturity	Unlimited
Parity	1 : 1
Emission price	8.58 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	9.69 €
Lowest since issue	0.83 €
Spread	0.01 €
Spread %	0.85%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.31 USD

Average target price

72.8 USD

Spread / Average Target

+27.03%

Consensus